A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting where good ideas are being implemented, it encourages their wider uptake.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Overall ranking Vacancies Funding Methodology Key Finding

News

All the latest news about the Access to Medicine Foundation, our research programmes and engagement activities. 

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

12 Oct 2017

The Lancet publishes commentary on AMR Benchmark

A new Commentary published today in The Lancet discusses the potential of the new Antimicrobial Resistance Benchmark to stimulate pharmaceutical compa...

05 Oct 2017

Latest framework for action by pharmaceutical companies on access to medicine

The world’s leading pharmaceutical companies have the power and the products to improve access to medicine. To help guide their actions, the Access to...

24 Aug 2017

Now online: first independent framework for assessing pharma company action on AMR

Today, the Access to Medicine Foundation publishes the methodology for its 2018 Antimicrobial Resistance Benchmark. It is the first independently deve...

09 Aug 2017

Online soon: new methodology for Antimicrobial Resistance Benchmark

The Access to Medicine Foundation will shortly publish the methodology for a new tool – an Antimicrobial Resistance Benchmark that will evaluate how p...

22 May 2017

New study finds wide variety in pharma companies’ cancer access programmes

Today, the Access to Medicine Foundation publishes the first analysis of pharmaceutical company actions to improve cancer care in the developing world...

21 Apr 2017

The Access to Medicine Foundation has moved to Amsterdam

The Access to Medicine Foundation has outgrown its former office in Haarlem and moved to a larger space in Amsterdam.

06 Mar 2017

New Access to Vaccines Index reveals first landscape of vaccine company actions to improve immunisation coverage

The 2017 Access to Vaccines Index reveals the first landscape of industry activity to improve immunisation coverage. It finds a high level of diversit...

14 Feb 2017

Out in March: the first Access to Vaccines Index

The first Access to Vaccines Index will be published on Monday 6 March, 2017. It is the first tool of its kind to present the current landscape of vac...

13 Dec 2016

Foundation to track pharma company progress on AMR

The Access to Medicine Foundation has started work on a new tool – an Antimicrobial Resistance Benchmark that will track how pharmaceutical companies...

01 Dec 2016

New analysis: Large pharmaceutical companies are developing five HIV/AIDS medicines for children

For World AIDS Day 2016, the Access to Medicine Foundation has analysed the pharmaceutical pipelines for HIV/AIDS from 20 of the world’s largest pharm...

29 Nov 2016

Coming up: 2016 Access to Medicine Index to launch in UK at Houses of Parliament

On Tuesday 6 December, members of the UK parliament will co-host the UK launch of the 2016 Access to Medicine Index. The event will focus on UK-based...

17 Nov 2016

2016 Index: from findings to change

Following the publication of the 2016 Access to Medicine Index, the Foundation team has begun a series of meetings and events to discuss its findings...

14 Nov 2016

New online: 2016 Access to Medicine Index

The 2016 Access to Medicine Index, published Monday, ranks 20 of the world’s largest pharmaceutical companies on their efforts to improve access...

08 Nov 2016

Which pharmaceutical companies have the most essential medicines and vaccines?

The new analysis by the Access to Medicine Foundation shows which large pharmaceutical companies are marketing the most essential medicines and vaccin...

02 Nov 2016

UNICEF covers the upcoming Access to Vaccines Index

Margot de Graaff from the UNICEF Netherlands magazine interviews Jayasree K Iyer and Suzanne Wolf regarding the pharmaceutical industry, the Access to...

24 Oct 2016

2016 Access to Medicine Index: out in November

The Access to Medicine Foundation is preparing a new iteration of its leading sustainability Index of pharmaceutical companies – the next Access to Me...

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.